Combination with gamma-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells

Zhu, Guannan and Yi, Xiuli and Haferkamp, Sebastian and Hesbacher, Sonja and Li, Chunying and Goebeler, Matthias and Gao, Tianwen and Houben, Roland and Schrama, David (2016) Combination with gamma-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells. CANCER LETTERS, 376 (1). pp. 43-52. ISSN 0304-3835, 1872-7980

Full text not available from this repository. (Request a copy)

Abstract

Oncogenic triggering of the MAPK pathway in melanocytes results in senescence, and senescence escape is considered as one critical step for melanocytic transformation. In melanoma, induction of a senescent like state by BRAF-inhibitors (BRAFi) in a fraction of treated cells - instead of killing - contributes to the repression of tumor growth, but may also provide a source for relapse. Here, we demonstrate that NOTCH activation in melanocytes is not only growth-promoting but it also protects these cells against oncogene-induced senescence. In turn, treatment of melanoma cells with an inhibitor of the NOTCH-activating enzyme gamma-secretase led to induction of a senescent-like status in a fraction of the cells but overall achieved only a moderate inhibition of melanoma cell growth. However, combination of gamma-secretase inhibitor (GSI) with BRAFi markedly increased the treatment efficacy particularly in long-term culture. Moreover, even melanoma cells starting to regrow after continuous BRAFi treatment - the major problem of BRAFi therapy in patients - can still be affected by the combination treatment. Thus, combining GSI with BRAFi increases the therapeutic efficacy by, at least partially, prolonging the senescent-like state of treated cells. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Item Type: Article
Uncontrolled Keywords: ONCOGENE-INDUCED SENESCENCE; N-CADHERIN; METASTATIC MELANOMA; MALIGNANT-MELANOMA; PRECURSOR LESIONS; TUMOR-SUPPRESSOR; MELANOCYTIC NEVI; NOTCH; MUTATIONS; PATHWAY; Melanoma; Notch; Senescence; BRAF inhibition
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 08 Apr 2019 08:53
Last Modified: 08 Apr 2019 08:53
URI: https://pred.uni-regensburg.de/id/eprint/3743

Actions (login required)

View Item View Item